about
Mitochondrial DNA backgrounds might modulate diabetes complications rather than T2DM as a wholeThe Possible Role of Flavonoids in the Prevention of Diabetic Complications"Inflammaging" as a Druggable Target: A Senescence-Associated Secretory Phenotype-Centered View of Type 2 DiabetesPharmacokinetic and pharmacodynamic evaluation of linagliptin for the treatment of type 2 diabetes mellitus, with consideration of Asian patient populationsGlycemic index, glycemic load and glycemic response: An International Scientific Consensus Summit from the International Carbohydrate Quality Consortium (ICQC).Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications?Acute hyperglycemia induces an oxidative stress in healthy subjectsTargets and tactics: the relative importance of HbA, fasting and postprandial plasma glucose levels to glycaemic control in type 2 diabetes.The glucose triad and its role in comprehensive glycaemic control: current status, future management.Postprandial glucose regulation: new data and new implications.A long-term "memory" of HIF induction in response to chronic mild decreased oxygen after oxygen normalization.Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control.Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring.Diabetes Interactive Diary: a new telemedicine system enabling flexible diet and insulin therapy while improving quality of life: an open-label, international, multicenter, randomized studyHyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications.Increased glycation and oxidative damage to apolipoprotein B100 of LDL cholesterol in patients with type 2 diabetes and effect of metformin.Personalized therapy algorithms for type 2 diabetes: a phenotype-based approach.Oxidative stress and glycemic regulation.Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysisThe post-prandial state and cardiovascular disease: relevance to diabetes mellitus.Insulin lispro protamine suspension in the treatment of patients with type 1 and type 2 diabetes mellitus: a systematic review of published data.Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.Oxidative stress evaluation in diabetes.ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collabOxidative stress and diabetic vascular complications.Mechanisms of tissue damage in the postprandial state.Age- and glycemia-related miR-126-3p levels in plasma and endothelial cells.Efficacy of insulin analogs in achieving the hemoglobin A1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials.The effects of diet on inflammation: emphasis on the metabolic syndrome.The protective effect of the Mediterranean diet on endothelial resistance to GLP-1 in type 2 diabetes: a preliminary report.The possible protective role of glucagon-like peptide 1 on endothelium during the meal and evidence for an "endothelial resistance" to glucagon-like peptide 1 in diabetesManagement of cardiovascular risk in diabetic patients: evolution or revolution?Nitrotyrosine: new findings as a marker of postprandial oxidative stress.Diet and glycaemia: the markers and their meaning. A report of the Unilever Nutrition Workshop.The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications.New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy.N-glycomic changes in serum proteins in type 2 diabetes mellitus correlate with complications and with metabolic syndrome parameters.Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with Type 2 diabetes.Oxidative stress in diabetes.
P50
Q21135340-419FB44D-7E8C-4FD8-8846-CDF7FD21CD97Q26746903-50EE7A3D-A515-4BD1-B17A-4A59E9B879B1Q26747251-79D49F19-32D7-4844-9394-D63C50C200CCQ26749524-3ECB14A2-E483-489F-A4CB-A7DDFA0525BBQ27693250-008837EE-D3D4-49C4-A4DF-78F7FA2B1999Q28079163-69E60CE9-B0CD-4493-994A-83ECB8115614Q28334713-40A94F41-FBE6-4D8A-BDFD-078F0B46A724Q28346605-802DCCDC-F8C1-4579-AB8C-F816268A4028Q30374513-9AF5DEA8-FD8D-47FC-BC8E-9925F7B706B0Q30393989-9A5CFBDA-E017-4441-A869-C42AAC1FB4EEQ31033684-42812AF4-8F6B-46EC-8595-656690EF8128Q33269618-7B9C029A-BAC9-499D-994C-E08E3144000EQ33505450-474C806D-C34F-4606-95F3-FE5201D73FD5Q33511008-49713802-ACBD-4DC3-AD89-428E30D557B1Q33556711-719BA045-B9CD-4A13-8329-5EE04B080197Q33749978-A5DA243F-791C-4B4A-9921-73CF47BF8D44Q33750626-84B281D1-F90B-4BBA-B0C9-12E2F6E93AB8Q33805824-A40C385E-3C78-4215-9D86-F781E9E82C0CQ33849770-D72AC420-DAAE-4430-B655-759951D2FA54Q33880174-7D786474-B209-4D76-8747-4F9A2268EB8CQ33883730-426C1FBB-82CB-4C78-80EB-FBC421952DDCQ34126929-14B27B6E-2F07-45C7-B026-50204AF2C66AQ34154404-6228AACD-C291-425D-B46D-391C6495CE16Q34317285-30D17D23-0BDB-46B2-9355-8DCB6583D8DEQ34368081-8D058C39-3292-47D3-9A18-192D5D4BBF5DQ34391178-4D3F603A-EF06-4828-8DDD-4173D28D4DBAQ34396987-BDF3ED56-41A5-4AE6-9F11-1B8985FEFBB9Q34461150-021AC405-D02B-4349-AD3B-9809D3CD3F0FQ34507342-31E7B7C4-58FE-4122-9399-A40B18089BF2Q34556641-6C1D5E8D-01B3-4DB5-8DAA-506EFA603864Q34558538-33E2ED19-C783-4280-AD44-BDDD8CC3F01BQ34583386-40ED3E83-1187-4ED8-9166-2B40F6249E38Q34680497-50FE74CC-A323-46BF-A8F5-82982F379F05Q34776242-5DC697C9-E4A2-435F-8C15-CF5CDE2AF1E0Q34997385-D15822BD-5928-48FB-AA61-3BAD63A554C8Q35090488-872E19A6-C5F5-44D6-9B26-CD6AF8FCB192Q35115544-E52B6B47-4CF2-4635-9D94-98BFAD689E2EQ35201538-025C3784-4866-4B39-A8C9-9A6A5CBE100AQ35228483-68DC89B0-EB21-400D-A411-AAD1BA1DB478Q35576066-ADE33749-A7F8-4763-91C1-F5B70C9FF4BC
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Antonio Ceriello
@ast
Antonio Ceriello
@en
Antonio Ceriello
@es
Antonio Ceriello
@fr
Antonio Ceriello
@nl
Antonio Ceriello
@sl
type
label
Antonio Ceriello
@ast
Antonio Ceriello
@en
Antonio Ceriello
@es
Antonio Ceriello
@fr
Antonio Ceriello
@nl
Antonio Ceriello
@sl
prefLabel
Antonio Ceriello
@ast
Antonio Ceriello
@en
Antonio Ceriello
@es
Antonio Ceriello
@fr
Antonio Ceriello
@nl
Antonio Ceriello
@sl
P106
P21
P31
P496
0000-0001-8122-3203